Highly selective norepinephrine reuptake inhibitors and...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/5375 (2006.01) A61P 13/02 (2006.01) A61P 13/10 (2006.01)

Patent

CA 2532330

Methods and compositions for treating humans suffering from, or preventing a human from suffering, a physiological or psychiatric disease, disorder, or a condition wherein inhibiting reuptake of nonpinephrine is a benefit are disclosed. The compositions comprise a compound having a pharmacological selectivity of serotonin (K i)/nonpinephrine (K i) of at least about 5000. Examples of such compounds include reboxetine, and more preferably optically pure (S,S) enantiomer of reboxetine. The methods generally include administration of a therapeutic amount of such compositions. Also disclosed are preparations of a medicament from the composition, and uses of the composition in a manufacture of the medicament to treat a human suffering from, or preventing a human from suffering, a physiological or psychiatric disease, disorder, or condition.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Highly selective norepinephrine reuptake inhibitors and... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Highly selective norepinephrine reuptake inhibitors and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Highly selective norepinephrine reuptake inhibitors and... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1755152

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.